How does evidence of cerebral amyloid angiopathy/microbleeds affect choices for secondary stroke prevention in patients with a history of ischemic stroke and atrial fibrillation?

Topics: Hematology • Neurology • Cardiology • Vascular Neurology • Atrial Fibrillation

How do you approach secondary stroke prevention for patients with ischemic stroke, atrial fibrillation, and signs of cerebral amyloid angiopathy/microbleeds on MRI but no prior intraparenchymal hemorrhage?

Answer from: at Academic Institution

This is a discussion I have with the patient, mentioning that the positive predictive value of cortically based cerebral microhemorrhages is not absolute, especially when there is a small number of them and there are no other signs of small vessel disease (such as FLAIR changes or enlarged peri-vasc...

Comments

at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
I agree with Dr. @Joshua Willey. If there is no cl...

Related Questions